AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Pennsylvania

HB 2058

Kratom product regulation

Status

Pending

2025–2026

Would regulate kratom through the Controlled Substance, Drug, Device and Cosmetic Act.

IntroducedNov 19, 2025 (done)
PassedNext step (current)
Signed— (upcoming)
Law in effect— (upcoming)

Type: Official legislature record
Substances: Kratom / 7-OH

Official text

Summary of official legislation

Would regulate kratom through the Controlled Substance, Drug, Device and Cosmetic Act.

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: palegis.us

Legislative history

November 19, 2025
Referred to House Health.

Loading bill…